Related Experiment Video
Updated: Aug 14, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
BRCA2 and Smad3 synergize in regulation of gene transcription
Olena Preobrazhenska1, Mariya Yakymovych, Takashi Kanamoto
1Ludwig Institute for Cancer Research, Box 595, Husargatan, 3, SE-751 24, Uppsala, Sweden.
Abstract:
Smad3 is an essential component in the intracellular signaling of transforming growth factor-beta (TGFbeta), which is a potent inhibitor of tumor cell proliferation. BRCA2 is a tumor suppressor involved in early onset of breast, ovarian and prostate cancer. Both Smad3 and BRCA2 possess transcription activation domains. Here, we show that Smad3 and BRCA2 interact functionally and physically. We found that BRCA2 forms a complex with Smad3 in vitro and in vivo, and that both MH1 and MH2 domains of Smad3 contribute to the interaction. TGFbeta1 stimulates interaction of endogenous Smad3 and BRCA2 in non-transfected cells. BRCA2 co-activates Smad3-dependent transcriptional activation of luciferase reporter and expression of plasminogen activator inhibitor-1 (PAI-1). Smad3 increases the transcriptional activity of BRCA2 fused to the DNA-binding domain (DBD) of Gal4, and reciprocally, BRCA2 co-activates DBD-Gal4-Smad3. Thus, our results show that BRCA2 and Smad3 form a complex and synergize in regulation of transcription.
Insights
The tumor suppressors BRCA2 and Smad3 physically interact and functionally cooperate. This complex formation and synergy enhance the regulation of gene transcription, impacting cellular processes.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Smad3 is crucial for transforming growth factor-beta (TGFbeta) signaling, inhibiting tumor cell proliferation.
- BRCA2 is a tumor suppressor gene linked to breast, ovarian, and prostate cancers.
- Both Smad3 and BRCA2 have transcription activation domains, suggesting potential functional interplay.
Purpose of the Study:
- To investigate the functional and physical interaction between Smad3 and BRCA2.
- To determine if BRCA2 influences Smad3-mediated transcriptional activity.
- To explore the synergistic effects of Smad3 and BRCA2 on gene regulation.
Main Methods:
- In vitro and in vivo complex formation assays to confirm physical interaction.
- Reporter gene assays (luciferase) to assess transcriptional activation.
- Co-immunoprecipitation to detect endogenous Smad3-BRCA2 complex formation.
- Analysis of Smad3 and BRCA2 interaction with DNA-binding domain fusions.
Main Results:
- Smad3 and BRCA2 form a stable complex both in vitro and in vivo.
- The MH1 and MH2 domains of Smad3 are involved in the interaction with BRCA2.
- Transforming growth factor-beta 1 (TGFbeta1) enhances the interaction between endogenous Smad3 and BRCA2.
- BRCA2 acts as a co-activator for Smad3-dependent transcription of PAI-1 and reporter genes.
- Smad3 and BRCA2 exhibit synergistic effects on transcriptional regulation.
Conclusions:
- BRCA2 and Smad3 physically interact and form a functional complex.
- This interaction leads to synergistic co-activation of transcription.
- The findings reveal a novel functional relationship between Smad3 and BRCA2 in gene regulation.
Related Concept Videos
Co-activators and Co-repressors
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Master Transcription Regulators
Co-activators and Co-repressors
MAPK Signaling Cascades
TGF - β Signaling Pathway

